Neurocognitive Assessment and Rehabilitation Market Report 2026

The neurocognitive assessment and rehabilitation market size has grown strongly in recent years. It will grow from $14.65 billion in 2025 to $16.02 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising prevalence of cognitive impairment disorders, early adoption of standardized neurocognitive tests, growth of hospital-based rehabilitation programs, increased awareness of neurological assessment, development of paper-based cognitive testing methods.

The neurocognitive assessment and rehabilitation market size is expected to see strong growth in the next few years. It will grow to $22.02 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to expansion of digital cognitive testing platforms, rising adoption of vr-based rehabilitation therapy, increasing use of ai-enabled assessment software, growth in demand for homecare cognitive therapy solutions, development of advanced neuromodulation devices. Major trends in the forecast period include increasing adoption of computerized cognitive assessment tools, growing demand for virtual reality-based rehabilitation, rising use of standardized neuropsychological tests, expansion of neurofeedback and tms-based therapy, increasing preference for home-based cognitive rehabilitation.

The rising prevalence of neurological disorders is expected to drive the growth of the neurocognitive assessment and rehabilitation market in the coming years. Neurological disorders are medical conditions affecting the nervous system, including the brain, spinal cord, and peripheral nerves, leading to symptoms such as muscle weakness, coordination difficulties, and cognitive impairments. Factors contributing to this rise include an aging population and the increasing prevalence of age-related conditions such as Alzheimer's disease and Parkinson's disease. Neurocognitive assessment helps evaluate cognitive function, supporting accurate diagnosis and treatment planning, while rehabilitation interventions aim to optimize neural functioning and improve quality of life through targeted therapies and strategies. For example, in October 2023, the World Federation of Neurology, a UK-based charity, reported that neurological disorders are now the second-leading cause of death and the leading cause of disability worldwide, affecting more than 40% of the global population, with the number of individuals living with brain disease projected to nearly double by 2050. Therefore, the growing prevalence of neurological disorders is driving demand for neurocognitive assessment and rehabilitation solutions.

Key companies in the neurocognitive assessment and rehabilitation market are developing innovative solutions, such as digital cognitive screening tools, to improve early detection of cognitive impairment and support clinical decision-making. These software-based tools evaluate cognitive functions such as attention, memory, processing speed, and executive function, providing rapid and accessible assessments in clinical settings. For instance, in March 2024, Linus Health, a US-based digital health company specializing in brain health, launched two evidence-based cognitive screening tools - the Hearing Screener and the Digital Trail Making Test Part B (D-TMT Part B) - at HIMSS24. These tools are designed to enhance the identification of cognitive decline, offering rapid, clinically validated assessments that support earlier intervention and improve routine screening practices.

In September 2023, Enlyte Group LLC, a US-based software company, acquired Therapy Direct LLC from Upstream Rehabilitation for an undisclosed amount. The acquisition aims to expand Enlyte’s clinical services and network offerings, reinforcing its commitment to providing high-quality rehabilitation solutions to meet evolving customer needs. Therapy Direct, a US-based subsidiary of Upstream Rehabilitation Inc., specializes in medical rehabilitation services, particularly physical therapy.

Major companies operating in the neurocognitive assessment and rehabilitation market are Cogstate Ltd, Posit Science Corporation, Lumos Labs Inc., The Magstim Company Ltd, MindMaze SA, CogniFit Inc, Cambridge Cognition Holdings plc, ImPACT Applications Inc., Neurotrack Technologies Inc., Neuroelectrics Corporation, SCHUHFRIED GmbH, Constant Therapy Health Inc., NeuronUP S.L., Qbtech AB, Neurometrix Inc., CogniVue Corporation, Neurohealth Associates LLP, BrainTrain Inc., NeuroEM Therapeutics Inc., HASOMED GmbH, Neurosoft Bioelectronics Corporation, AnthroTronix Inc., Flow Neuroscience AB, NPsych Limited.

North America was the largest region in the neurocognitive assessment and rehabilitation market in 2025. The regions covered in the neurocognitive assessment and rehabilitation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurocognitive assessment and rehabilitation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the neurocognitive assessment and rehabilitation market by increasing the costs of imported digital assessment devices, VR therapy equipment, and neuromodulation tools used in cognitive rehabilitation. Hospitals, rehab centers, and homecare providers in regions dependent on imported technology - particularly Asia-Pacific and Europe - are experiencing higher procurement costs and delays. Segments involving computerized assessments, VR therapy platforms, and TMS devices are most affected by price fluctuations. However, tariffs are encouraging local manufacturing and software development, promoting innovation in cost-effective digital cognitive rehabilitation tools.

The neurocognitive assessment and rehabilitation market research report is one of a series of new reports that provides neurocognitive assessment and rehabilitation market statistics, including neurocognitive assessment and rehabilitation industry global market size, regional shares, competitors with a neurocognitive assessment and rehabilitation market share, detailed neurocognitive assessment and rehabilitation market segments, market trends and opportunities, and any further data you may need to thrive in the neurocognitive assessment and rehabilitation industry. This neurocognitive assessment and rehabilitation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Neurocognitive rehabilitation refers to therapeutic interventions designed to evaluate, manage, and improve cognitive impairments resulting from neurological conditions, brain injuries, or psychological disorders. This field focuses on assessing cognitive functions such as memory, attention, language, and problem-solving skills and implementing strategies to restore or compensate for deficits.

The main components of neurocognitive assessment and rehabilitation include neurocognitive assessment testing and neurorehabilitation therapy. Neurocognitive assessment testing involves standardized evaluations that measure a patient’s cognitive abilities to identify impairments and guide treatment planning. Neurorehabilitation therapy comprises structured interventions - such as cognitive exercises, memory training, attention retraining, and problem-solving strategies - aimed at improving overall cognitive function. These services are provided by hospitals, rehabilitation centers, clinics, home care settings, and physiotherapy centers and are offered by organizations ranging from large enterprises to small and medium-sized enterprises (SMEs).

The neurocognitive assessment and rehabilitation market consists of revenues earned by entities by providing services for individualized rehabilitation planning, cognitive training, psychoeducation, and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The neurocognitive assessment and rehabilitation market also includes sales of software applications, wearable devices, virtual reality systems, brain stimulation devices, and specialized exercise equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.